Stock report · Delisted · Nasdaq
SHL Telemedicine Ltd American Depositary Shares (SHLT)
2.05USD Delisted Final close · Apr 2, 2025
SHLT no longer trades. SHL Telemedicine Ltd American Depositary Shares was delisted from the Nasdaq in April 2025.
All prices on this page are historical. The last trade was on April 2, 2025, at $2.05.
SHLT stock price history
Final trading statistics
- Final close
- $2.05
- Final trading day
- Apr 2, 2025
- Market cap at delisting
- $33.60M
- Shares outstanding
- 16.39M
- Final 52-week range
- $1.85 – $6.73
- Avg. volume (final 3 mo.)
- 5,118
- All-time high
- $21.30 · Apr 2023
- All-time low
- $1.92 · Mar 2025
- Return since IPO
- -86.0%
- Beta
- 0.29
- Book value / share
- $4.11
- Price / book
- 0.50
About SHL Telemedicine Ltd American Depositary Shares
SHL Telemedicine, with its subsidiaries, developed and sold personal telemedicine products in Israel, Europe and elsewhere. Its devices included SmartHeart, a mobile 12-lead ECG used to detect heart attacks, and the CardioSen'C and Cardio'B 12-lead ECG transmitters.
It also offered a communication module that sent readings from blood pressure, weight, oxygen (TelePulse Oximeter), breath (TeleBreather) and glucose devices to its telemedicine centers, and TelePress for home blood pressure checks. Services were sold by subscription to patients, doctors, hospitals and health insurers.
The company worked with Mayo Clinic on a study of outcomes in the 90 days after a heart attack for SmartHeart users, and with the Hebrew University of Jerusalem and Hadassah Medical Center. It was incorporated in 1986 and based in Tel Aviv, Israel.
Its ADSs were delisted from the Nasdaq in April 2025, with the last trade on April 2, 2025 at $2.05.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Tel Aviv
- Employees
- 583
- IPO date
- April 3, 2023
- Delisted
- April 2, 2025
- SEC CIK
- 1166834
SHL Telemedicine Ltd American Depositary Shares financials before the delisting
The last 5 fiscal years SHL Telemedicine Ltd American Depositary Shares reported as a public company, fiscal year ending December.
SHLT revenue and net income
SHLT earnings per share
SHLT annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $56.78M | −$28.1M | — |
| FY2023 | $57.08M | −$7.1M | — |
| FY2022 | $59.00M | −$76.0K | — |
| FY2021 | $49.58M | −$14.1M | — |
| FY2020 | $40.16M | $278.0K | — |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
SHL Telemedicine Ltd American Depositary Shares stock FAQ
What happened to SHL Telemedicine Ltd American Depositary Shares stock?
SHL Telemedicine Ltd American Depositary Shares was delisted from the Nasdaq in April 2025. The final close was $2.05 on April 2, 2025.
Can I still buy SHLT stock?
No. SHLT is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on April 2, 2025.
What was the last price of SHLT?
SHLT last closed at $2.05 on April 2, 2025, which valued the company at about $33.60M.
How did SHL Telemedicine Ltd American Depositary Shares do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, SHL Telemedicine Ltd American Depositary Shares reported revenue of $56.78M and net income of −$28.1M.
When did SHL Telemedicine Ltd American Depositary Shares go public?
SHL Telemedicine Ltd American Depositary Shares shares started trading on April 3, 2023.
SHLT no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.